Clinical TrialID 2119

Cortisone and QTc-Interval

NCT03082339

QTc-interval

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2119
Evidence Id
2119
Core Evidence Id
2119
Source Clinical Trial Id
2090
Herb2 Clinical Trial Id
HBCT002090
Nct Id
NCT03082339
Title
Cortisone and QTc-Interval
Status
Completed
Phase
Study Result
No
Study Condition
QTc-interval
Study Type
Observational
Study Design
Observational Model: |Time Perspective: p
Intervention
OTHER: Cortisone
Intervention Allocation
Intervention Model
Intervention Mask
Intervention Purpose
Gender
All
Age
Adult, Older_Adult
Enrollment
105
Outcome Measure
Duration of QTc-interval, daily ECG controls and measuring QTc-interval, 1 week
Sponsor Collaborator
Asklepios Neurological Clinic Bad Salzhausen|University of Giessen
Funded By
OTHER
Location
University Giessen, Gießen, 35394, Germany|Neurologische Klinik Bad Salzhausen, Nidda, 63667, Germany
Other Id
QTc25416
Start Date
2017-04-01
Primary Completion Date
2020-04-25
Completion Date
2020-04-25
First Posted
2017-03-17
Results First Posted
Last Update Posted
2020-05-04
Study Document
Study Url
https://clinicaltrials.gov/study/NCT03082339
Title Cn
Title En
Cortisone and QTc-Interval
Bilingual Status
semi_complete